Prevalence of and motives for pharmacological neuroenhancement in Switzerland-results from a national Internet panel

Maier, Larissa J, Haug, Severin, Schaub, Michael P

DOI: 10.5167/uzh-112079
Published: 2016
Container: Not recorded
Publisher: Wiley-Blackwell
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.5167/uzh-112079,
  title = {Prevalence of and motives for pharmacological neuroenhancement in Switzerland-results from a national Internet panel},
  author = {Maier, Larissa J and Haug, Severin and Schaub, Michael P},
  year = {2016},
  doi = {10.5167/uzh-112079},
  url = {https://doi.org/10.5167/uzh-112079}
}

RIS

TY  - JOUR
TI  - Prevalence of and motives for pharmacological neuroenhancement in Switzerland-results from a national Internet panel
AU  - Maier, Larissa J
AU  - Haug, Severin
AU  - Schaub, Michael P
PY  - 2016
DO  - 10.5167/uzh-112079
UR  - https://doi.org/10.5167/uzh-112079
ER  -

APA

J, M. L., Severin, H., & P, S. M. (2016). Prevalence of and motives for pharmacological neuroenhancement in Switzerland-results from a national Internet panel. https://doi.org/10.5167/uzh-112079

Source records

datacite · retrieved 2026-11-10T10:17:59.000Z